Netherlands· NL-71057782beb9

Elidel 10 mg/g, crème

A pimecrolimus product containing pimecrolimus, registered in Netherlands by Viatris Healthcare Limited. The same ATC class is registered in 13 of our 19 countries.

ATC D11AH02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about pimecrolimusAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Pimecrolimus is registered in 13 of 19 countries.

Countries holding a registration under ATC D11AH02 (pimecrolimus), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search pimecrolimus products by name

Pimecrolimus · ATC D11AH02

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: PIMECROLIMUS
Manufacturer: Viatris Healthcare Limited
Country: Netherlands (NL)
ATC code: D11AH02
ATC class: Pimecrolimus
Defined daily dose: 20 mg, T
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
28742

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

217 interactions on record for pimecrolimus.

Graded by severity as the source publishes them — 9 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check pimecrolimus against other medicines How interaction checks work

Pimecrolimus · interactions on record

217 records

9 moderate
83 minor
125 info

Most severe, free to view

FostamatinibB02BX09moderate
EchinaceaD03AH02moderate
TemsirolimusL01EG01moderate
SirolimusL01EG04moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pimecrolimus in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pimecrolimus products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Elidel
Belgium · Elidel
Bulgaria · Елидел
Cyprus · Elidel
Czechia · Elidel
Germany · Elidel
Denmark · Elidel
Estonia · Elidel
Spain · Elidel
Finland · Elidel
United Kingdom (Northern Ireland) · Elidel
Greece · Elidel
Croatia · Elidel
Hungary · Elidel
Iceland · Elidel
Italy · Elidel
Lithuania · Elidel
Luxembourg · Elidel
Latvia · Elidel
Malta · Elidel
Norway · Elidel
Poland · Elidel
Portugal · Elidel
Romania · Elidel
Sweden · Elidel
Slovenia · Elidel
Slovakia · Elidel

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/6f41888b-cfce-4eaf-bf88-cb13b71845c4
GET /v1/drugs/6f41888b-cfce-4eaf-bf88-cb13b71845c4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Crème",
  "route": "Cutaan gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h28742_smpc.pdf",
  "strength": null,
  "atc_label": "Pimecrolimus",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg28742",
  "excipients": [
    "BENZYLALCOHOL (E 1519)",
    "CETYLALCOHOL",
    "CITROENZUUR 0-WATER (E 330)",
    "MONO- EN DIGLYCERIDEN VAN VETZUREN (E 471)",
    "NATRIUMCETOSTEARYLSULFAAT",
    "NATRIUMHYDROXIDE (E 524)",
    "OLEYLALCOHOL",
    "PROPYLEENGLYCOL (E 1520)",
    "STEARYLALCOHOL",
    "TRIGLYCERIDEN MIDDELLANGE KETEN",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "PIMECROLIMUS"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h28742.pdf",
  "authorised_at": "2003/04/28",
  "procedure_number": "DK/H/0339/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "28742",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about pimecrolimus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console